Conventional and novel diagnostic biomarkers of acute myocardial infarction: A promising role for circulating microRNAs

Research output: Contribution to journalArticle

Abstract

Biomarkers play a critical role in the diagnosis of acute myocardial infarction (AMI), especially in patients with atypical clinical and/or electrocardiographic presentation or co-morbidities, like the elderly. High-sensitivity assays based on specific biomarkers (e.g. cardiac troponins) enabling earlier AMI diagnosis have recently become available in clinical practice. Although no single biomarker of myocardial necrosis is ever likely to afford AMI diagnosis, a combination including different biomarkers for necrosis and ischemia, like new circulating molecules (microRNAs), could enhance diagnostic specificity. We review the recent literature on conventional and novel AMI biomarkers, with special emphasis on circulating microRNAs.

Original languageEnglish
Pages (from-to)547-558
Number of pages12
JournalBiomarkers
Volume18
Issue number7
DOIs
Publication statusPublished - Nov 2013

Keywords

  • Acute myocardial infarction
  • Biomarkers
  • Cardiac troponin
  • Diagnosis
  • MicroRNAs

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis

Fingerprint Dive into the research topics of 'Conventional and novel diagnostic biomarkers of acute myocardial infarction: A promising role for circulating microRNAs'. Together they form a unique fingerprint.

  • Cite this